| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871581 | The Annals of Thoracic Surgery | 2016 | 5 Pages |
Abstract
The presence of dysphagia in patients with esophageal cancer was highly predictive of T3-4 disease by EUS. On the basis of this finding, approximately 50% of patients currently undergoing staging EUS at our institution could potentially forgo EUS before neoadjuvant therapy. Patients without dysphagia, however, should still undergo EUS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
R. Taylor MD, Inderpal S. MD, Rachel BS, Camelia S. MD, MS, Manjit S. MD, David R. MD, Prasad S. MD, James MD, David J. MD, Valerie W. MD, Nabil P. MD, MS,